Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation

Wiener, 1965, The cellular pathology of experimental hypertension. II. Arteriolar hyalinosis and fibrinoid change, Am J Pathol, 47, 457 Mauer, 1992, Relationship of systemic blood pressure to nephropathology in insulin-dependent diabetes mellitus, Kidney Int, 41, 736, 10.1038/ki.1992.115 Bertani, 1996, Structural basis of diabetic nephropathy in microalbuminuric NIDDM patients: A light microscopy study, Diabetologia, 39, 1625, 10.1007/s001250050625 Fioretto, 1995, Sequential renal biopsies in insulin-dependent diabetic patients: Structural factors associated with clinical progression, Kidney Int, 48, 1929, 10.1038/ki.1995.493 Bazzi, 2015, Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis, Nephrology, 20, 11, 10.1111/nep.12339 Snanoudj, 2011, Specificity of histological markers of long-term CNI nephrotoxicity in kidney transplant recipients under low-dose cyclosporine therapy, Am J Transplant, 11, 2635, 10.1111/j.1600-6143.2011.03718.x Stegall, 2011, The histology of solitary renal allografts at 1 and 5 years after transplantation, Am J Transplant, 11, 698, 10.1111/j.1600-6143.2010.03312.x Mihatsch, 1998, The side-effects of ciclosporine-A and tacrolimus, Clin Nephrol, 49, 356 Myers, 1984, Cyclosporine-associated chronic nephropathy, N Engl J Med, 311, 699, 10.1056/NEJM198409133111103 Nankivell, 2004, Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology, Transplant, 78, 557, 10.1097/01.TP.0000128636.70499.6E Nankivell, 2003, The natural history of chronic allograft nephropathy, N Engl J Med, 349, 2326, 10.1056/NEJMoa020009 Fioretto, 2011, Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients, Clin J Am Soc Nephrol, 6, 101, 10.2215/CJN.03850510 Kubal, 2012, Chronic kidney disease after nonrenal solid organ transplantation: A histological assessment and utility of chronic allograft damage index scoring, Transplantation, 93, 406, 10.1097/TP.0b013e318240e984 Nizze, 1988, Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants, Clin Nephrol, 30, 248 Feutren, 1992, International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases, N Engl J Med, 326, 1654, 10.1056/NEJM199206183262502 Antonovych, 1988, Cyclosporine A-induced arteriolopathy, Transplant Proc, 20, 951 Nankivell, 2016, Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: Comparison of cyclosporine and tacrolimus eras, Transplantation, 100, 1723, 10.1097/TP.0000000000001243 Mihatsch, 1988, Histopathology of cyclosporine nephrotoxicity, Transplant Proc, 20, 759 Sis, 2006, Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients, Am J Transplant, 6, 1444, 10.1111/j.1600-6143.2006.01302.x Solez, 2008, Banff 07 classification of renal allograft pathology: Updates and future directions, Am J Transplant, 8, 753, 10.1111/j.1600-6143.2008.02159.x Marcussen, 1995, Reproducibility of the Banff classification of renal allograft pathology. Inter- and intraobserver variation, Transplantation, 60, 1083, 10.1097/00007890-199511270-00004 Brocker, 2012, Arteriolar lesions in renal transplant biopsies: Prevalence, progression, and clinical significance, Am J Pathol, 180, 1852, 10.1016/j.ajpath.2012.01.038 Sis, 2010, Cluster analysis of lesions in kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation, and scarring, Am J Transplant, 10, 421, 10.1111/j.1600-6143.2009.02938.x Einecke, 2009, Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure, Am J Transplant, 9, 2520, 10.1111/j.1600-6143.2009.02799.x Gaston, 2010, Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure, Transplantation, 90, 68, 10.1097/TP.0b013e3181e065de Naesens, 2014, The histology of kidney transplant failure: A long-term follow-up study, Transplantation, 98, 427, 10.1097/TP.0000000000000183 Reeve, 2013, Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies, Am J Transplant, 13, 645, 10.1111/ajt.12079 Sellares, 2013, Molecular diagnosis of antibody-mediated rejection in human kidney transplants, Am J Transplant, 13, 971, 10.1111/ajt.12150 Halloran, 2013, Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study, Am J Transplant, 13, 2352, 10.1111/ajt.12387 Halloran, 2013, Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: An international prospective study (INTERCOM), Am J Transplant, 13, 2865, 10.1111/ajt.12465 Haas, 2014, Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions, Am J Transplant, 14, 272, 10.1111/ajt.12590 Naesens, 2016, Calcineurin inhibitor nephrotoxicity in the era of antibody-mediated rejection, Transplantation, 100, 1599, 10.1097/TP.0000000000001244 Venner, 2016, Relationships among injury, fibrosis, and time in human kidney transplants, JCI Insight, 1, e85323, 10.1172/jci.insight.85323 Halloran, 2016, Identifying subphenotypes of antibody-mediated rejection in kidney transplants, Am J Transplant, 16, 908, 10.1111/ajt.13551 Morozumi, 2004, Cyclosporine nephrotoxicity: How does it affect renal allograft function and transplant morphology?, Transpl Proc, 36, 251S, 10.1016/j.transproceed.2004.01.027 Ekberg, 2007, Reduced exposure to calcineurin inhibitors in renal transplantation, N Engl J Med, 357, 2562, 10.1056/NEJMoa067411 Halloran, 2016, A molecular biopsy test for probability of non-adherence, Am J Transplant, 16, 349 Halloran, 2015, Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients, J Am Soc Nephrol, 26, 1711, 10.1681/ASN.2014060588 Sellares, 2012, Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and non-adherence, Am J Transplant, 12, 388, 10.1111/j.1600-6143.2011.03840.x Wiebe, 2012, Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant, 12, 1157, 10.1111/j.1600-6143.2012.04013.x Moreso, 2012, Early subclinical rejection as a risk factor for late chronic humoral rejection, Transplantation, 93, 41, 10.1097/TP.0b013e31823bb647